Release Date: 15/02/17 08:15 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 62.87KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%